Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Haven't seen this before, but interesting anyway:
"Also in August, a US company personalising immune therapies for solid tumour cancers raised further capital to complete the Phase 1 buildout of a UK manufacturing facility in Sawston, Cambridge.
Northwest Biotherapeutics in Maryland raised $5 million growth capital and topped this up by securing a special purpose competitive loan of $1.77m from the Department for Business, Energy & Industrial Strategy. Northwest is developing DCVax® personalised immune therapies for solid tumour cancers and is pursuing an intensive program of manufacturing preparations and planning as it approaches top line data from its Phase III trial."
Article link: https://www.businessweekly.co.uk/news/biomedtech/hands-across-water-bio-bonds-stand-test-time
Not crazy. BUT, this is day trading IMO. We are in a range until PPS can justify more than 1.3B market cap. That is all up to NWBO mgmt. They need to say something after 4 months and one week post data lock PR.
This is a 3 month daily chart. Hopefully scary in a good way as the trend looks up. Description of two dojis "Now imagine what happens when you see not one, but two Dojis! This is a world war between buyers and sellers. After such a war, you are most likely to have a knock-out winner. In other words, after 2 Dojis in a row there is a high probability of a strong move."
Yes, but tenuously above. It looks very indecisive and wound tight. It will move, IMO, which way is the question. Support at $1.50 and resistance at $1.62. Closer to breaking through to the upside but farther to fall on the downside.
Assumption, IMO. I don't think there are as many warrants being converted as some may think. They have plenty of time and a LOT are with shareholders who believe in the science and are not under pressure to convert or sell. Maybe a strategic plan with some shareholders to slowly convert and fill the coffers?
That's why I said IMO. Not made up. You are inferring they are still waiting for the data. The company will not tell us when they became unblinded. I assert 4-6 weeks was plenty of time for independent statisticians to add data to tables and send to the company....and that is longer than usual, even for larger trials. That would have been Mid-to-late November.
Old news. He is referencing Preparing topline release and a publication. Analysis from outside statisticians is long past. Company has had data for a couple months IMO.
We need a LEAK! So many people must have their hands on this data right now. Since the company isn't saying anything, we need it from another source. Someone will tell a friend or family member if data is game-changing. It's human nature.
No, it means he was immunocompromised. Old, sick, diabetes, etc. That's who dies from this. And if accurately counted for comorbidities, would be no where near the current death total. 99+% survive.
They did, according to DI, tell us what they are doing in the Oct 5th PR with this: "... who will analyze the data with the statisticians in preparation for public announcement and scientific publication."
4-6 weeks after this they should have been unblinded. So, IMO, they have had the data for almost three months.
I am at a total loss for guessing when topline PR will be. Could be tomorrow or it could be July, who knows. That is why the stock is sitting where it is. Not to mention the fact that with over a billion dollar valuation and no money, no product, no news....it won't get much higher than this, if at all.
There he goes again. "We told you what we are doing in the Oct 5th PR."
Never a mention of timing or an update. Brutal. It's been over a third of a year since that vague PR.
I think we all agree that positive data moves this much higher. It's been 4 months and 4 days since data lock. That's the problem. No One here knows when we will get the data, that's the real problem. No one even bothers to call DI anymore. It's ridiculous.
Sawston build out as an indicator of success, yes. Cognate I am sure is moving with their own business plan, of which NWBO may be a small part. They are not spending $182 million guessing we will have a marketable product.
Just tested the $1.61 Ask, showing 200. I bought 200, still there. Phantom ask, they seem to just keep reloading.
Man, they keep loading up shares to keep us from running. Can someone really be selling large shares at this point? I would have thought we shook out the traders and newbies by now.
Let's see if we can push through $1.60 and hold it!
I love charts and I hope they show me direction with greater probability. However, NWBO is an enigma in so many ways. OTC, AF, LP, 14 years, etc., etc....and yet we still have a 1.3 billion market cap and no one knows when we get news. That's why we are stuck here, IMO.
Not worried. Very Resourceful. Only problem is ammo is scarce.
Somehow it is being absorbed. Accumulation?
This was as of October 5th:
"The statisticians will proceed as quickly as possible with analyses of the raw data and prepare summaries of the Trial results for review by the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts, who will analyze the data with the statisticians in preparation for public announcement and scientific publication."
Independent Statisticians. One group, preparing summaries. Meaning plugging data into tables. It is not their job to give a thumbs up or down on results. Package it into standard tables and forward to company for analysis. Let's say 45 days. That means company was unblinded on or about November 25th.
Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts. Assuming timing above,These groups have now had the unblinded data for about 9 weeks.
That is more than enough time to review, share comments back and forth and then create topline release. It has to be the journal peer review that is now taking the rest of the time. I am guessing less than two weeks away.
I believe in UFO's.
I think the answer is yes when it comes to OTC stocks. If they go out of business and stock is zero, who is counting shares? And, yes, there are many who believe the electronic trading systems, MM's and offshore shorting hedgies can evade the failure to deliver rules. Smith on Stocks reporting, among others, on illegal short selling details how difficult this is to track and prove.
There are those, including the CEO, LP, and senior VP, LG, who continue to believe there are hundreds of millions of naked short shares out there on NWBO. I tend to doubt that number but wouldn't be surprised if there were tens of millions.
I think I actually believe it this time.
No. But they have been "clear" they want the Journal to be published closely behind the topline PR. And, we will not get a one-page topline PR, IMO. It will be a comprehensive analysis PR with nothing left to doubt.
They will. I am sticking with my belief they have had unblinded data since mid-to-late November. Add another month of internal review by all stakeholders. Now we are near year end. So, I cannot imagine it would take that long to get a commitment from a Journal, given we have had another 4-6 weeks since internal review. Maybe down to logistics and timing. Peer review questions and back and forth along with topline PR writing and when to PR.
Whether there are naked shorts or not, a concerted buying effort into topline release would really move the stock, IMO, and truly show if MM's are holding us here or if they would get out of the way.
I just hope the REDDIT and wallstreetbets groups get a hold of that article and start piling into NWBO....
I disagree. Good News is Good News. No News is a slow death. We need topline! Friday is 120 days since data lock.
Has anyone seen this publication from November. Compares all types of treatments for gbm currently out there and in trials. Mentions DCVAX and approval in Switzerland?
https://res.mdpi.com/d_attachment/pharmaceuticals/pharmaceuticals-13-00389/article_deploy/pharmaceuticals-13-00389-v2.pdf
Charles Payne has been a financial advisor for 35 years, and still has his advisory business outside of his tv show. He knows what he is talking about.
Next Thursday will be 4 (FOUR) months since data lock. 120 days....If they have had the data unblinded since mid-late November, as I assume, they have to be ready now. Who on the SAB, Steering committee, lead investigators, etc. hasn't been chomping at the bit to get a read of this data? They now how important it might be (or is) to get to patients. Has to be an early February topline release, IMO.
It would be fabulous if a trading group would see the squeeze opportunity with NWBO. GME was/is a failing model and shorts took that bet. Organized retail took them out! In NWBO, you actually have a potential game-changing cancer treatment with results "imminent." Combine those two facts with a concerted buying effort and BOOM! Just can't use Robinhood...
We need a strong close. We have two days of shooting star candlesticks. If we can't close the top of the candle today it would be bearish IMO. $1.65 seems to be the resistance right now, 4 times it has pushed us back. PSAR has changed to a positive trend but we need volume through $1.65 to confirm a larger move.
For the PPS pop, I hope he is correct. Impossible to know until we get positive news. And, it is impossible to know when we get news, so here we are.
I don't believe there is any analyst covering NWBO. This has likely been out there since the stock was $12.
NWBO short shares per FINRA as of 1/15 is just over 15 million shares. Will be absorbed in one day with positive topline with likely only a small upward price impact. If there are truly naked short shares as LEs and LP assert, we will see large volumes and larger spike.